Kratom Research Institute

Research · 2026-01-14

7-OH-Enriched Kratom Preparation Shows No Significant Genotoxic Hazard in New Lab Study

Source: Toxicology Reports

Why it matters

As regulators weigh whether to classify 7-hydroxymitragynine as a controlled substance, this Thai government study addresses a key unknown: whether 7-OH-enriched kratom preparations damage DNA. The answer has direct implications for product safety standards and regulatory decisions.

The big picture

Genotoxicity — the ability of a substance to damage DNA — is one of the core safety tests for new drugs and supplements. While kratom's opioid-like effects have received substantial scrutiny, its genotoxic potential has been largely understudied. Thailand's Ministry of Public Health researchers used both computer modeling and laboratory cell assays to fill that gap for a 7-OH-concentrated preparation, the same type the FDA has sought to schedule.

Key findings

What they say

The authors concluded that "while a weak positive chromosomal effect was noted at a highly cytotoxic concentration, the overall weight of evidence suggests that this 7-OHMG-enriched Kratom preparation does not present a significant genotoxic hazard under the conditions tested."

Bottom line

A 7-OH-enriched kratom product showed no meaningful DNA-damaging activity in a rigorous Thai government safety study, though the findings apply only to genotoxicity and not to kratom's addiction or other toxicity risks.